Results 201 to 210 of about 70,074 (346)

Chondrodystrophic Dogs as a Preclinical Large Animal Model of Discogenic Back Pain

open access: yesJOR SPINE, Volume 8, Issue 3, September 2025.
This study aims to validate an underutilized canine preclinical model of discogenic back pain model by deep phenotyping several structural and pain associated outcomes with novel findings in the areas of RNA sequencing and whole patch clamp of canine dorsal root ganglion neurons.
Mary K. Heimann   +18 more
wiley   +1 more source

Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat [PDF]

open access: bronze, 2003
Sachia G. Khasar   +3 more
openalex   +1 more source

Animal Models of Disc Degeneration Using Puncture Injury: A 20 Year Perspective

open access: yesJOR SPINE, Volume 8, Issue 3, September 2025.
This review of surgically induced IVD puncture injury animal models presents an evolution over decades to include many variations simulating distinct clinical phenotypes of IVDD, and recommends reporting a common set of injury features to facilitate cross‐study comparison.
Charu Jain   +8 more
wiley   +1 more source

A Conceptual Review of Naturally Occurring Toxins and Venoms as Peptide Blockers to Combat Chronic Low Back Pain

open access: yesJOR SPINE, Volume 8, Issue 3, September 2025.
This review explores the therapeutic potential of naturally occurring venom‐derived peptides, particularly from reptiles and insects, as novel calcium channel blockers for managing chronic low back pain caused by intervertebral disc degeneration.
James Melrose   +4 more
wiley   +1 more source

Zebrafish as a Versatile Model Organism: From Tanks to Treatment

open access: yesMedComm – Future Medicine, Volume 4, Issue 3, September 2025.
The zebrafish, with its optical transparency and genetic tractability, serves as a versatile in vivo platform for biomedical research. This review underscores its significance in modeling a wide spectrum of human diseases—from cancer to metabolic disorders—and in leveraging cutting‐edge technologies like CRISPR and TALENs.
Rupali Srivastava   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy